+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

S

Actively Recruiting

Healthy Volunteer

Researchers are studying the safety of Efluelda, a high-dose trivalent influenza vaccine, in adults aged 65 years or older under routine clinical practice in the Republic of Korea. This observational, open-label, multi-center active safety surveillance study aims to monitor the occurrence of adverse events and adverse drug reactions in this population following vaccination. The study complies with local risk management regulations to ensure thorough monitoring. Participants will receive one intramuscular dose of Efluelda on Day 1. The study does not involve any comparison groups or placebo and is conducted in a standard healthcare setting. The participation duration is approximately 28 to 35 days, which may be extended to 36 to 42 days if the second visit is not completed on time. During the study, participants will be monitored for various reactions, including solicited injection site reactions and systemic reactions within 7 days after vaccination. Unsolicited adverse events, adverse drug reactions, serious adverse events, and adverse events of special interest will be tracked from vaccination until the last participant contact, up to about 42 days. This monitoring helps researchers understand the vaccines safety profile in older adults over the short term.

Age: 65Years +All Genders
15 locations